North America Immunohistochemistry Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Immunohistochemistry Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Immunohistochemistry Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Immunohistochemistry Market Regional Analysis

6.2 North America Immunohistochemistry Market Revenue 2019-2028 (US$ Million)

6.3 North America Immunohistochemistry Market Forecast Analysis

7. North America Immunohistochemistry Market Analysis – by Application

7.1 Diagnostics

7.1.1 Overview
7.1.2 Diagnostics: North America Immunohistochemistry Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Drug Testing

7.2.1 Overview
7.2.2 Drug Testing: North America Immunohistochemistry Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Immunohistochemistry Market Analysis – by Product

8.1 Antibodies

8.1.1 Overview
8.1.2 Antibodies: North America Immunohistochemistry Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Equipment

8.2.1 Overview
8.2.2 Equipment: North America Immunohistochemistry Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Reagents

8.3.1 Overview
8.3.2 Reagents: North America Immunohistochemistry Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Kits

8.4.1 Overview
8.4.2 Kits: North America Immunohistochemistry Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Immunohistochemistry Market Analysis – by End User

9.1 Hospitals and Diagnostic Laboratories

9.1.1 Overview
9.1.2 Hospitals and Diagnostic Laboratories: North America Immunohistochemistry Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Research Institutes

9.2.1 Overview
9.2.2 Research Institutes: North America Immunohistochemistry Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Immunohistochemistry Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Immunohistochemistry Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 North America Immunohistochemistry Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Immunohistochemistry Market Breakdown, by Application
10.2.1.1.2 US: North America Immunohistochemistry Market Breakdown, by Product
10.2.1.1.3 US: North America Immunohistochemistry Market Breakdown, by End User

10.2.1.2 Canada: North America Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Immunohistochemistry Market Breakdown, by Application
10.2.1.2.2 Canada: North America Immunohistochemistry Market Breakdown, by Product
10.2.1.2.3 Canada: North America Immunohistochemistry Market Breakdown, by End User

10.2.1.3 Mexico : North America Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Immunohistochemistry Market Breakdown, by Application
10.2.1.3.2 Mexico : North America Immunohistochemistry Market Breakdown, by Product
10.2.1.3.3 Mexico : North America Immunohistochemistry Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Abcam plc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Agilent Technologies, Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Bio SB

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 BIO-RAD LABORATORIES INC.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Cell Signaling Technology, Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Danaher

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 F. HOFFMANN-LA ROCHE LTD.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 MERCK KGaA

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 PerkinElmer Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 THERMO FISHER SCIENTIFIC INC.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Immunohistochemistry Market

Analysis By Application (Diagnostics and Drug Testing), Product (Antibodies, Equipment, Reagents, and Kits), and End User (Hospitals and Diagnostic Laboratories, Research Institutes, and Others)